COMMUNIQUÉS West-GlobeNewswire

Pediapharm Announces Closing of Subscription Receipt Offering for Total Gross Proceeds of $62 Million

11/10/2018 - 18:14

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Oct. 11, [...]

Virbac : revenue grew by +5.5% at constant exchange rates at the end of September 2018

11/10/2018 - 17:46

Revenue grew by +5.5% at constant exchange rates at the end of September 2018 KEY FIGURES Revenue Year-to-date September 2018 €634.3 million Total growth +0.7% Growth at constant exchange rates +5.5% Growth at constant [...]

Virbac : chiffre d'affaires en croissance de +5,5% à taux de change constants à fin septembre 2018

11/10/2018 - 17:46

Chiffre d'affaires en croissance de +5,5% à taux de change constants à fin septembre 2018 CHIFFRES CLÉS Chiffre d'affaires Neuf mois 2018 634,3 m€ Évolution globale +0,7% Croissance à taux de change constants +5,5% [...]

TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Presentation at the 34th Congress of ECTRIMS

11/10/2018 - 17:00

Annualized Relapse Rate (ARR) of 0.07 observed for all patients on Phase 2 trial ECTRIMS data review conference call to be held today, October 11, 2018, 19:30 CEST/1:30pm ET NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- [...]

Zynerba Pharmaceuticals to Present at the 2018 BIO Investor Forum

11/10/2018 - 16:47

DEVON, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]

Corporate Update To Shareholders: Preparatory Work For Regulatory Filings On Track

11/10/2018 - 16:45

HASBROUCK HEIGHTS, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Following many shareholder enquiries in recent weeks Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide shareholders with a brief update on [...]

OncBioMune Advancing ProscaVax Towards Second Phase 2 Clinical Trial for Prostate Cancer with Protocol Submission to FDA

11/10/2018 - 15:36

BATON ROUGE, La., Oct. 11, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Vital Therapies Provides Strategic Update

11/10/2018 - 15:27

SAN DIEGO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company that has been developing ELAD®, a cell-based therapy targeting the treatment of liver failure, today announced [...]

MedAustron selected C-RAD Catalyst PT

11/10/2018 - 15:00

MedAustron selected C-RAD Catalyst PT C-RAD announced today that it signed a purchasing agreement with MedAustron – the first Ion-therapy treatment site in Austria. The agreement entails the acquisition of C-RAD’s most [...]

ClearCorrect and Dental Monitoring connect doctors and patients with mobile clear aligner monitoring

11/10/2018 - 15:00

ROUND ROCK, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- ClearCorrect , LLC, a leading manufacturer of clear aligners, is joining forces with Dental Monitoring SAS to empower doctors to monitor the progress of orthodontic [...]

SeaSpine Prices Public Offering of Common Stock

11/10/2018 - 14:57

CARLSBAD, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of [...]

Carequality Seeks Community Input As It Expands Governance to FHIR

11/10/2018 - 14:55

VIENNA, Va., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Carequality , a national-level, interoperability trusted exchange framework , is actively seeking input from the healthcare community as it adds support for FHIR-based [...]

ADMA Biologics Provides Regulatory Update for BIVIGAM®

11/10/2018 - 14:48

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 11, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]

Teladoc Health Announces Availability of Best Doctors Oncology Insight in Canada

11/10/2018 - 14:35

Now available to Sun Life Financial clients, Oncology Insight provides patients facing cancer access to the world’s leading oncologists, backed by recommended treatment options from IBM Watson for Oncology TORONTO, Oct [...]

Cerner to Release Third Quarter 2018 Earnings Results October 25

11/10/2018 - 14:30

KANSAS CITY, Mo., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its third quarter 2018 earnings results after the market closes Thursday, Oct. 25. Following the [...]

numares’ ground breaking method to precisely determine glomerular filtration rate presented at ASN Kidney Week

11/10/2018 - 14:30

REGENSBURG, Germany, Oct. 11, 2018 (GLOBE NEWSWIRE) -- numares along with clinical study partners from three European medical centers will be presenting their results on a novel method for the accurate assessment of [...]

HempAmericana Unveils New Web Presence Ahead of Expanded Commercial Operations

11/10/2018 - 14:30

NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce the official launch of the Company’s new website ( www.hempamericana [...]

Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatment with ARIKAYCE® (amikacin liposome inhalation suspension)

11/10/2018 - 14:30

BRIDGEWATER, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that the Company [...]

Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD

11/10/2018 - 14:30

MINNEAPOLIS, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]